(firstQuint)STA-21 Topical Efficacy on Psoriasis.

 Two discrete psoriatic lesions with a similar size (approximately coin-sized) and clinical severity are selected in each patient.

 Clinical assessment of psoriatic lesion severity is performed at the baseline and at 1 and 2 (end of treatment) using the scores of erythema, induration, scaling on a scale of 0-4 by two observers.

 Since STA-21 inhibits Stat3 activation, which is essential for disease activity of psoriasis, topical application of 0.

2% STA-21 in Vaseline should improve psoriasis in two weeks.

.

 STA-21 Topical Efficacy on Psoriasis@highlight

The clinical assessment of patients with plaque-type psoriasis is performed by open, intrapatient comparison of 0.

2% STA-21 with vehicle(Vaseline) alone within a 2 week period.

